GTBP
GTBP
NASDAQ · Biotechnology

Gt Biopharma Inc

$3.95
-0.01 (-0.25%)
Analyst Consensus
Strong Buy
7
Analysts
Moderate
Coverage
Buy 6 86%
Hold 1 14%
Sell 0 0%
Price Target
Analyst Price Target +529.1% upside
Low Target $15.48
Average Target $24.85
High Target $31.61
Current Price $3.95
Current
$3.95
Target
$24.85
$15.48 $24.85 avg $31.61
Scenario Analysis
Bear Case
$15.48
291.9%
Low target
Base Case
$24.85
+529.1%
Avg target
Bull Case
$31.61
+700.3%
High target
Risk/Reward
2.4x
Favorable
Price in Context
52-Week High
$28.75
-86.3% from high
52-Week Low
$4.80
+-17.7% from low
Target vs 52W High
$24.85
-13.6% vs high
Peer Consensus — Biotechnology
Stock Consensus Analysts Buy % Target Upside
ABBV
Abbvie Inc
Strong Buy 38 82% $257.58 -12.5%
AMGN
Amgen Inc
Hold 42 43% $190.87 -59.0%
GILD
Gilead Sciences Inc
Strong Buy 36 83% $362.68 +115.4%
VRTX
Vertex Pharmaceuticals Inc
Strong Buy 39 82% $438.34 -18.5%
MRNA
Moderna Inc
Hold 31 32% $149.45 -35.4%
REGN
Regeneron Pharmaceuticals
Buy 36 72% $76.80 -91.9%
NTRA
Natera Inc
Strong Buy 31 90% $142.91 -55.7%
RVMD
Revolution Medicines Inc
Strong Buy 31 94% $114.11 -35.3%